2022 - 2024 Basic research to elucidate the impact of genomic diversity acquisition on the endometrial embryo implantation environment and carcinogenesis inhibition
2019 - 2022 Pathological and genomic analyses of uterine sarcoma by next generation sequencing
2018 - 2021 Search for novel biomarkers of heart failure by comprehensive genetic analysis of autopsy heart
2016 - 2019 Pathological and genomic analyses of gastric-type adenocarcinoma of the uterine cervix
2016 - 2019 Investigation of pathophysiologies by genomic analyses in interstitial cystitis
2014 - 2016 Pathological and genomic study of ovarian mucinous adenocarcinoma
2010 - 2015 Cancer genomics analysis and biomarker discovery under therapeutic modification
2012 - 2014 Role of microRNA in cystic fluid of ovarian clear cell adenocarcinoma
2010 - 2011 Investigation of the development of ovarian clear cell adenocarcinoma with emphasis on its precursor
Show all
Papers (51)：
Masafumi Horie, Yoshiyuki Akiyama, Hiroto Katoh, Satoru Taguchi, Masaki Nakamura, Keishi Mizuguchi, Yukinobu Ito, Takashi Matsushita, Tetsuo Ushiku, Shumpei Ishikawa, et al. APRIL/BAFF upregulation is associated with clonal B-cell expansion in Hunner-type interstitial cystitis. The Journal of Pathology. 2024
Hanano Ando, Yuki Katoh, Osamu Kobayashi, Yuji Ikeda, Hideaki Yahata, Takashi Iwata, Toyomi Satoh, Azusa Akiyama, Daichi Maeda, Yumiko Hori-Hirose, et al. Low CD86 expression is a predictive biomarker for clinical response to the therapeutic HPV vaccine, IGMKK16E7: Results of a post-hoc analysis. JNCI cancer spectrum. 2024
Yukio Homma, Yoshiyuki Akiyama, Jang Hwan Kim, Yao-Chi Chuang, Seong Jin Jeong, En Meng, Takeya Kitta, Jia-Fong Jhang, Akira Furuta, Kyu-Sung Lee, et al. Definition Change and Update of Clinical Guidelines for Interstitial Cystitis and Bladder Pain Syndrome. Lower urinary tract symptoms. 2024. 16. 5. e12532
Tumor Heterogeneity can be Assessed by Exome Sequencing of Cell-free DNA in Post-mortem Blood Sample: The “Liquid Autopsy”
(107th Annual Meeting, The United States and Canadian Academy of Pathology 2018)
Clinicopathological significance of ARID1A immunoreactivity in ovarian clear cell carcinoma
(100th Annual Meeting, The United States and Canadian Academy of Pathology 2011)
Frequent Glypican-3 Overexpression in Ovarian Clear Cell Adenocarcinoma.
(2009)
Education (2)：
2006 - 2010 東京大学大学院医学系研究科博士課程
1998 - 2004 The University of Tokyo Faculty of Medicine School of Medicine
Professional career (1)：
医学博士 (東京大学)
Work history (5)：
2021/04 - 現在 金沢大学医薬保健研究域医学系 分子細胞病理学 教授
2018/04 - 2021/03 Osaka University Graduate School of Medicine
2014/04 - 2018/03 Akita University Graduate School of Medicine
2012/04 - 2014/03 The University of Tokyo Faculty of Medicine University Hospital, Department of Pathology
2010/04 - 2012/03 The University of Tokyo Graduate School of Medicine
Committee career (5)：
2022 - 現在 WHO Classification of Tumours Editorial Board, Standing Member
2017/04 - 現在 日本婦人科病理学会 理事
2017/01 - 現在 Pathology International 刊行委員
2016/12 - 現在 JSAWI 世話人
2015 - 現在 日本病理学会 学術評議員
Awards (3)：
2022 - 日本病理学会 症例研究賞演説 (B演説)
2014 - 日本病理学会 B演説
2012/11 - 国際病理アカデミー日本支部 病理診断学術奨励賞
Association Membership(s) (7)：
THE JAPANESE CANCER ASSOCIATION
, 日本婦人科腫瘍学会
, 日本間質性膀胱炎研究会
, 日本臨床細胞学会
, 国際病理アカデミー日本支部
, 日本婦人科病理学会
, THE JAPANESE SOCIETY OF PATHOLOGY
